Table 2

Strength and endurance of the dominant quadriceps

Healthy elderly controlsCOPD patients
QMVC kg49±1322±10**
QMVC % pred110±2963±27**
QTlim min30±06.9±5.3**
QTlim-final fEMG % initial99±1287±13**
QTlim-V'O2max mL·kg−1·min−19.6±3.68.5±2.2
QTlim‐ΔV'O2 rest versus end242±197164±123
QTlim‐HRmax beat·min−1118±2296±16**
QTlim‐HRmax % pred59±1163±14
QTlim‐ΔHR rest versus end43±2622±23
QTlimV'Emax L·min−134±1731±12
QTlimV'Emax % pred18±955±6**
QTlim‐dyspnoea end VAS1±15±3**
QTlim‐thigh discomfort VAS6±210±0**
Thigh length cm39.9±1.040.9±2.8
Thigh perimeter cm49.1±4.144.6±6.4
  • Data are presented as mean±sd

  • Both heart rate (HR) and minute ventilation (V'E) values appear referenced to values from Jones et al. 33 for incremental cycle ergometry

  • COPD: chronic obstructive pulmonary disease

  • QMVC: quadriceps maximal strength during maximum voluntary contraction

  • QTlim: quadriceps endurance using a normalised exercise with a load equivalent to 10% of the QMVC and a contraction frequency of 12 min−1

  • fEMG: median frequency of the electromyographic spectra

  • V'O2: CO2 production

  • HRmax: maximum HR

  • V'Emax: maximum minute ventilation

  • VAS: visual analogic scale

  • **: p<0.01